Cargando…

RETRACTED: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?

Detalles Bibliográficos
Autores principales:	Funck-Brentano, Christian, Salem, Joe-Elie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255131/ https://www.ncbi.nlm.nih.gov/pubmed/32450109 http://dx.doi.org/10.1016/S0140-6736(20)31174-0

Ejemplares similares

Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
por: Palmeira, Vitória Andrade, et al.
Publicado: (2020)

Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
por: Biguetti, Claudia, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
por: Zahr, Noël, et al.
Publicado: (2021)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Hydroxychloroquine in the prevention of COVID-19 mortality
por: Jorge, April
Publicado: (2021)

Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database
por: Nguyen, Lee S., et al.
Publicado: (2020)

Insights from nanomedicine into chloroquine efficacy against COVID-19
por: Hu, Tony Y., et al.
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
por: Marmor, Michael F.
Publicado: (2020)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
por: Singh, Bhagteshwar, et al.
Publicado: (2021)

Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021)

Hydroxychloroquine for COVID19: The curtains close on a comedy of errors
por: Schwartz, Ilan S, et al.
Publicado: (2022)

Chloroquine/hydroxychloroquine overdose
por: McKeever, Rita
Publicado: (2020)

Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)

The COVID-19 pandemic in the USA: what might we expect?
por: Chowell, Gerardo, et al.
Publicado: (2020)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
por: Kamp, Timothy J., et al.
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
por: Colson, Philippe, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine increase risk of death in COVID-19
Publicado: (2020)

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection
por: Carafoli, Ernesto
Publicado: (2021)

Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
por: Bahadoram, Mohammad, et al.
Publicado: (2021)

Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes
por: Naddaf, Elie, et al.
Publicado: (2021)

Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
por: Mehra, Mandeep R, et al.
Publicado: (2020)

RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
por: Mehra, Mandeep R, et al.
Publicado: (2020)

COVID-19 vaccine results might inform malaria vaccine strategies
por: Abeywickrema, Movin, et al.
Publicado: (2022)

Use of chloroquine in viral diseases
por: Savarino, Andrea
Publicado: (2011)

Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19
por: Uzelac, Ilija, et al.
Publicado: (2020)

How repeated influenza vaccination effects might apply to COVID-19 vaccines
por: Thompson, Mark G, et al.
Publicado: (2022)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
por: Stevens, David M., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine for cancer therapy
por: Manic, Gwenola, et al.
Publicado: (2014)

Reported ADRs with chloroquine or hydroxychloroquine
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d5m6rh00k3hc6j4anotr0p2agv